News
To get a sense of who is truly in control of Bristol-Myers Squibb Company (NYSE:BMY), it is important to understand the ...
38m
Stocktwits on MSNRetail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here's What Investors Are ThinkingBristol Myers Squibb (BMY) announced on Friday that its drug, evaluated for myelofibrosis-associated anemia, did not meet its ...
We interviewed experts in the field of pediatric rheumatology to understand gaps in juvenile idiopathic arthritis management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results